Revenue: The sum of all revenue fields included for a company's operating activities.
AbCellera Biologics Inc. (ABCL) had Revenue of $10.64M for the most recently reported fiscal quarter, ending 2026-09-30.
| Income Statement Financials | |
|
Revenue |
$10.64M |
$-40.76M |
|
-- |
|
$10.64M |
|
$63.95M |
|
$-53.31M |
|
$10.50M |
|
$-42.81M |
|
$-42.81M |
|
$-40.76M |
|
$-40.76M |
|
$-40.76M |
|
$-40.76M |
|
$-53.31M |
|
$-44.70M |
|
318.05M |
|
318.05M |
|
$-0.13 |
|
$-0.13 |
|
| Balance Sheet Financials | |
$876.16M |
|
$410.05M |
|
$623.71M |
|
$1.50B |
|
$70.47M |
|
-- |
|
$366.89M |
|
$437.36M |
|
$1.06B |
|
$976.30M |
|
$1.06B |
|
326.33M |
|
| Cash Flow Statement Financials | |
$19.31M |
|
$-197.18M |
|
$214.22M |
|
$155.25M |
|
$190.76M |
|
$35.51M |
|
$35.97M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
12.43 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-501.13% |
|
-501.13% |
|
-- |
|
-402.41% |
|
-383.10% |
|
$11.74M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
0.59 |
|
151.97 |
|
-3.84% |
|
-4.17% |
|
-2.72% |
|
-3.84% |
|
$3.26 |
|
$0.04 |
|
$0.06 |
|